Intermolecular V(D)J recombination is prohibited specifically at the joining step

Molecular Cell

Volumn 3, Issue 3, 1999, Pages 331-338

  Han, Jung Ok ^a   Steen, Sharri B ^a,c   Roth, David B ^a,b  

^a Dept of Microbiol and Immunology ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN J CHAIN;

ANIMAL CELL; ARTICLE; CHO CELL; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA CLEAVAGE; GENE REARRANGEMENT; GENETIC RECOMBINATION; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE RECEPTOR GENE;

EID: 0033106433     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80460-8     Document Type: Article

References (38)

1. Agrawal, A., and Schatz, D.G. (1997). RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell 89, 43-53.
2. Bailey, S.N., and Rosenberg, N. (1997). Assessing the pathogenic potential of the V(D)J recombinase by interlocus immunoglobulin light-chain gene rearrangement. Mol. Cell. Biol. 17, 887-894.
3. Bogue, M., and Roth, D.B. (1996). Mechanism of V(D)J recombination. Curr. Opin. Immunol. 8, 175-180.
4. Bogue, M.A., Wang, C., Zhu, C., and Roth, D.B. (1997). V(D)J recombination in ku86-deficient mice: Distinct effects on coding, signal, and hybrid joint formation. Immunity 7, 37-47.
5. Craig, N.L. (1988). The mechanism of conservative site-specific recombination. Annu. Rev. Genet. 22, 77-105.
6. Eastman, Q.M., Leu, T.M.J., and Schatz, D.G. (1996). Initiation of V(D)J recombination in vitro obeying the 12/23 rule. Nature 380, 85-88.
7. Guidos, C.J., Williams, C.J., Grandal, I., Knowles, G., Huang, M.T.F., and Danska, J.S. (1996). V(D)J recombination activates a p53-dependent DNA damage checkpoint in scidlymphocyte precursors. Genes Dev. 10, 2038-2054.
8. Han, J.-O., Steen, S.B., and Roth, D.B. (1997). Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products. Mol. Cell. Biol. 17, 2226-2234.
9. Han, J.-O., Erskine, L.A., Purugganan, M.M., Stamato, T.D., and Roth, D.B. (1998). V(D)J recombination intermediates and non-standard products in xrcc4-deficient cells. Nucleic Acids Res. 26, 3769-3775.
10. Hempel, W.M., Stanhope-Baker, P., Mathieu, N., Huang, F., SchlisSel, M.S., and Ferrier, P. (1998). Enhancer control of V(D)J recombination at the TCRβ locus: Differential effects on DNA cleavage and joining. Genes Dev. 12, 2305-2317.
11. Hesse, J.E., Lieber, M.R., Gellert, M., and Mizuuchi, K. (1987). Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V(D)J joining signals. Cell 49, 775-783.
12. Hesse, J.E., Lieber, M.R., Mizuuchi, K., and Gellert, M. (1989). V(D)J recombination: A functional definition of the joining signals. Genes Dev. 3, 1053-1061.
13. Hiom, K., and Gellert, M. (1998). Assembly of a 12/23 paired signal complex: A critical control point in V(D)J recombination. Mol. Cell 1, 1011-1019.
14. Korsmeyer, S.J. (1992). Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu. Rev. Genet. 10, 785-807.
15. Lewis, S.M. (1994). P nucleotide insertions and the resolution of hairpin DNA structures in mammalian cells. Proc. Natl. Acad. Sci. USA 91, 1332-1336.
16. Lewis, S.M., Hesse, J.E., Mizuuchi, K., and Gellert, M. (1988). Novel strand exchanges in V(D)J recombination. Cell 55, 1099-1107.
17. Lieber, M.R., Hesse, J., Mizuuchi, K., and Gellert, M. (1987). Developmental stage specificity of the lymphoid V(D)J recombination activity. Genes Dev. 1, 751-761.
18. Lieber, M.R., Hesse, J.E., Lewis, S., Bosma, G.C., Rosenberg, N., Mizuuchi, K., Bosma, M.J., and Gellert, M. (1988). The defect in murine severe combined immune deficiency: Joining of signal sequences but not coding segments in V(D)J recombination. Cell 55, 7-16.
19. Lipkowitz, S., Stern, M.-H., and Kirsch, I.R. (1990). Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes. J. Exp. Med. 172, 409-418.
20. Lista, F., Bertness, V., Guidos, C., Danska, J.S., and Kirsch, I.R. (1997). The absolute number of trans-rearrangements between the TCRG and TCRB loci is predictive of lymphoma risk: A severe combined immune deficiency (SCID) murine model. Cancer Res. 57, 4408-4413.
21. Livak, F., and Schatz, D.G. (1996). T-cell receptor α locus V(D)J recombination by-products are abundant in thymocytes and mature T cells. Mol. Cell. Biol. 16, 609-618.
22. Melek, M., Gellert, M., and van Gent, D.c. (1998). Rejoining of DNA by the RAG1 and RAG2 proteins. Science 280, 301-303.
23. Mizuuchi, K. (1983). In vitro transposition of bacteriophage mu: A biochemical approach to a novel replication reaction. Cell 35, 785-794.
24. Nacht, M., Strasser, A., Chan, Y.R., Harris, A.W., Schlissel, M., BronSon, R.T., and Jacks, T. (1996). Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10, 2055-2066.
25. Ramsden, D.A., Paull, T.T., and Gellert, M. (1997). Cell-free V(D)J recombination. Nature 388, 488-491.
26. Roth, D.B., Menetski, J.P., Nakajima, P.B., Bosma, M.J., and Gellert, M. (1992). V(D)J recombination: Broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell 70, 983-991.
27. Roth, D.B., Zhu, C., and Gellert, M. (1993). Characterization of broken DNA molecules associated with V(D)J recombination. Proc. Natl. Acad. Sci. USA 90, 10788-10792.
28. Sadofsky, M.J., Hesse, J.E., McBlane, J.F., and Gellert, M. (1993). Expression and V(D)J recombination activity of mutated RAG-1 proteins. Nucleic Acids Res. 21, 5644-5650.
29. Sadofsky, M.J., Hesse, J.E., and Gellert, M. (1994). Definition of a core region of RAG-2 that is functional in V(D)J recombination. NuCleic Acids Res. 22, 1805-1809.
30. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular ClonIng: A Laboratory Manual (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
31. Sleckman, B.P., Gorman, J.R., and Alt, F.W. (1996). Accessibility control of antigen-receptor variable-region gene assembly: Role of cis-acting elements. Annu. Rev. Immunol. 14, 459-481.
32. Steen, S.B., Gomelsky, L., and Roth, D.B. (1996). The 12/23 rule is enforced at the cleavage step of V(D)J recombination in vivo. Genes Cells 1, 543-553.
33. Tycko, B., and Sklar, J. (1990). Chromosomal translocations in lymphoid neoplasia: A reappraisal of the recombinase model. CanCer Cells 2, 1-8.
34. Tycko, B., Palmer, J.D., and Sklar, J. (1989). T cell receptor gene trans-rearrangements: Chimeric γ-δ genes in normal lymphoid tissues. Science 245, 1242-1246.
35. Tycko, B., Coyle, H., and Sklar, J. (1991). Chimeric γδ signal joints: implications for the mechanism and regulation of T cell receptor gene rearrangement. J. Immunol. 147, 705-713.
36. van Gent, D.C., Ramsden, D.A., and Gellert, M. (1996). The RAG1 and RAG2 proteins establish the 12/23 rule in V(D)J recombination. Cell 85, 107-113.
37. Zhu, C., and Roth, D.B. (1995). Characterization of coding ends in thymocytes of scid mice: Implications for the mechanism of V(D)J recombination. Immunity 2, 101-112.
38. Zhu, C., Bogue, M.A., Lim, D.-S., Hasty, P., and Roth, D.B. (1996). Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86, 379-389.